• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Body Composition, Cardiometabolic Risk Factors and Comorbidities in Psoriasis and the Effect of HLA-C*06:02 Status: The HUNT Study, Norway.

作者信息

Solvin Åshild Øksnevad, Bjarkø Vera V, Thomas Laurent F, Berrospi Patricia, Hveem Kristian, Saunes Marit, Åsvold Bjørn O, Løset Mari

机构信息

K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, NTNU - Norwegian University of Science and Technology, Trondheim, Norway.

Department of Dermatology, Clinic of Orthopedics, Rheumatology and Dermatology, St. Olavs hospital, Trondheim University Hospital, Trondheim, Norway.

出版信息

Acta Derm Venereol. 2023 May 5;103:adv5209. doi: 10.2340/actadv.v103.5209.

DOI:10.2340/actadv.v103.5209
PMID:37144512
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10171087/
Abstract
摘要

相似文献

1
Body Composition, Cardiometabolic Risk Factors and Comorbidities in Psoriasis and the Effect of HLA-C*06:02 Status: The HUNT Study, Norway.银屑病患者的身体成分、心血管代谢危险因素及合并症以及HLA-C*06:02状态的影响：挪威HUNT研究
Acta Derm Venereol. 2023 May 5;103:adv5209. doi: 10.2340/actadv.v103.5209.
2
Potential Differences in the Cardiometabolic Risk Profile of Patients with Psoriatic Disease according to Their HLA-C∗06 Status.根据 HLA-C∗06 状态，银屑病患者的心血管代谢风险特征可能存在差异。
Biomed Res Int. 2022 Jan 27;2022:1451193. doi: 10.1155/2022/1451193. eCollection 2022.
3
HLA-C*01:02 and HLA-A*02:07 Confer Risk Specific for Psoriatic Patients in Southern China.HLA-C*01:02和HLA-A*02:07赋予中国南方银屑病患者特定风险。
J Invest Dermatol. 2019 Sep;139(9):2045-2048.e4. doi: 10.1016/j.jid.2019.02.027. Epub 2019 Mar 13.
4
Combined effects of HLA-Cw6, body mass index and waist-hip ratio on psoriasis vulgaris in Chinese Han population.HLA-Cw6、体重指数和腰臀比在中国汉族人群寻常型银屑病中的联合作用
J Dermatol Sci. 2008 Nov;52(2):123-9. doi: 10.1016/j.jdermsci.2008.04.016. Epub 2008 Jun 27.
5
The HLA-Cw12 Allele Is an Important Susceptibility Allele for Psoriasis and Is Associated with Resistant Psoriasis in the Turkish Population.HLA - Cw12等位基因是银屑病的重要易感基因，且与土耳其人群中的抵抗性银屑病相关。
ScientificWorldJournal. 2019 Jun 25;2019:7848314. doi: 10.1155/2019/7848314. eCollection 2019.
6
The HLA-C*06 allele as a possible genetic predisposing factor to psoriasis in South Indian Tamils.HLA - C*06等位基因作为南印度泰米尔人患银屑病的一种可能的遗传易感因素。
Arch Dermatol Res. 2016 Apr;308(3):193-9. doi: 10.1007/s00403-016-1618-y. Epub 2016 Jan 21.
7
HLA-C and TNF gene polymorphisms are associated with psoriasis in Brazilian patients.HLA - C和TNF基因多态性与巴西患者的银屑病相关。
Int J Dermatol. 2016 Jan;55(1):e16-22. doi: 10.1111/ijd.12894. Epub 2015 Oct 15.
8
HLA-Cw1 and Psoriasis.HLA-Cw1 与银屑病。
Am J Clin Dermatol. 2021 May;22(3):339-347. doi: 10.1007/s40257-020-00585-1. Epub 2021 Jan 18.
9
The association of ERAP1 and ERAP2 single nucleotide polymorphisms and their haplotypes with psoriasis vulgaris is dependent on the presence or absence of the HLA-C*06:02 allele and age at disease onset.ERAP1和ERAP2单核苷酸多态性及其单倍型与寻常型银屑病的关联取决于HLA-C*06:02等位基因的有无以及疾病发病年龄。
Hum Immunol. 2018 Feb;79(2):109-116. doi: 10.1016/j.humimm.2017.11.010. Epub 2017 Nov 26.
10
HLA-C locus and genetic susceptibility to psoriatic arthritis in Romanian population.罗马尼亚人群中HLA - C基因座与银屑病关节炎的遗传易感性
Tissue Antigens. 2011 Apr;77(4):325-8. doi: 10.1111/j.1399-0039.2010.01624.x.

引用本文的文献

1
Exploring Interaction between Genetically Predicted Body Mass Index and Serum 25-Hydroxyvitamin D Levels on the Odds for Psoriasis in UK Biobank and the HUNT Study: A Factorial Mendelian Randomization Study.在英国生物银行和HUNT研究中探索基因预测的体重指数与血清25-羟维生素D水平之间的相互作用对银屑病发病几率的影响：一项析因孟德尔随机化研究
JID Innov. 2024 Dec 4;5(2):100336. doi: 10.1016/j.xjidi.2024.100336. eCollection 2025 Mar.
2
Searching for a Novel HLA-Cw6-Linked Cardiometabolic Endotype in Psoriatic Disease.寻找银屑病中一种新的与HLA-Cw6相关的心脏代谢内型。
Biomedicines. 2024 Sep 25;12(10):2174. doi: 10.3390/biomedicines12102174.
3
A partitioned polygenic risk score reveals distinct contributions to psoriasis clinical phenotypes across a multi-ethnic cohort.分区多基因风险评分揭示了多民族队列中银屑病临床表型的不同贡献。
J Transl Med. 2024 Sep 11;22(1):835. doi: 10.1186/s12967-024-05591-z.
4
Analysis of Clinical and Genetic Factors of Obesity and Psoriasis Concomitance-The Influence of Body Mass Composition, Prevalence of Mood Disorders, Environmental Factors and Gene Polymorphisms (rs9939609, rs1558902).肥胖与银屑病共病的临床及遗传因素分析——身体成分、情绪障碍患病率、环境因素及基因多态性（rs9939609、rs1558902）的影响
Biomedicines. 2024 Feb 25;12(3):517. doi: 10.3390/biomedicines12030517.
5
Influence of the HLA-Cw6 Allele and Gene Variants on the Cardiometabolic Risk Profile of Patients with Psoriatic Disease.HLA-Cw6等位基因及基因变异对银屑病患者心脏代谢风险谱的影响。
J Clin Med. 2024 Feb 1;13(3):845. doi: 10.3390/jcm13030845.
6
An Observational Study of 147 Psoriasis Patients: Overweightness and Obesity as a Significant Clinical Factors Correlated with Psoriasis.一项 147 例银屑病患者的观察性研究：超重和肥胖是与银屑病相关的重要临床因素。
Medicina (Kaunas). 2023 Nov 15;59(11):2006. doi: 10.3390/medicina59112006.

本文引用的文献

1
The HUNT study: A population-based cohort for genetic research.HUNT研究：一项基于人群的基因研究队列。
Cell Genom. 2022 Oct 12;2(10):100193. doi: 10.1016/j.xgen.2022.100193.
2
Cohort Profile Update: The HUNT Study, Norway.队列简介更新：挪威HUNT研究。
Int J Epidemiol. 2023 Feb 8;52(1):e80-e91. doi: 10.1093/ije/dyac095.
3
Differences in Clinical Features and Comorbid Burden between HLA-C∗06:02 Carrier Groups in >9,000 People with Psoriasis.在 >9000 名银屑病患者中，HLA-C∗06:02 携带组的临床特征和合并症负担存在差异。
J Invest Dermatol. 2022 Jun;142(6):1617-1628.e10. doi: 10.1016/j.jid.2021.08.446. Epub 2021 Nov 10.
4
Metabolic Syndrome and Psoriasis: Mechanisms and Future Directions.代谢综合征与银屑病：机制及未来方向
Front Immunol. 2021 Jul 23;12:711060. doi: 10.3389/fimmu.2021.711060. eCollection 2021.
5
Comorbid obesity and history of diabetes are independently associated with poorer treatment response to biologics at 6 months: A prospective analysis in Corrona Psoriasis Registry.合并肥胖症和糖尿病史与生物制剂治疗6个月时较差的治疗反应独立相关：来自科罗纳银屑病登记处的前瞻性分析
J Am Acad Dermatol. 2022 Jan;86(1):68-76. doi: 10.1016/j.jaad.2021.06.883. Epub 2021 Jul 10.
6
Long-term Outcomes and Prognosis in New-Onset Psoriasis.新发银屑病的长期结局与预后
JAMA Dermatol. 2021 Apr 14;157(6):1-8. doi: 10.1001/jamadermatol.2021.0734.
7
Psoriatic disease and body composition: A systematic review and narrative synthesis.银屑病与人体成分：系统评价与叙述性综合。
PLoS One. 2020 Aug 13;15(8):e0237598. doi: 10.1371/journal.pone.0237598. eCollection 2020.
8
National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study.银屑病的国家、地区和全球流行病学：系统分析和建模研究。
BMJ. 2020 May 28;369:m1590. doi: 10.1136/bmj.m1590.
9
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities.联合 AAD-NPF 指南：关注并重视共病，以管理和治疗银屑病。
J Am Acad Dermatol. 2019 Apr;80(4):1073-1113. doi: 10.1016/j.jaad.2018.11.058. Epub 2019 Feb 13.
10
HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis.HLA-C*06:02 基因型是银屑病生物治疗反应的预测性生物标志物。
J Allergy Clin Immunol. 2019 Jun;143(6):2120-2130. doi: 10.1016/j.jaci.2018.11.038. Epub 2018 Dec 20.